Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn’s Disease

INTRODUCTION: The effect of mesalazine in treating active Crohn’s disease (CD) remains controversial, possibly due to the various formulae of mesalazine used to treat inflammation located in different regions of the digestive tract. METHODS: This exploratory, multicenter, uncontrolled, open-label st...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Yasuo, Iida, Mitsuo, Ito, Hiroaki, Tachikawa, Naoto, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767719/
https://www.ncbi.nlm.nih.gov/pubmed/26883035
http://dx.doi.org/10.1007/s40268-015-0113-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767719/
https://www.ncbi.nlm.nih.gov/pubmed/26883035
http://dx.doi.org/10.1007/s40268-015-0113-9

Ejemplares similares